Trial Outcomes & Findings for Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos (NCT NCT02110095)
NCT ID: NCT02110095
Last Updated: 2020-12-11
Results Overview
Tattoo clearance will be measured using baseline and 2 month post treatment photos using a photographic scale. The scale ranges from 0 to 10, where 10 is 100% improvement from the baseline photo.
COMPLETED
NA
15 participants
2 months post last treatment
2020-12-11
Participant Flow
Participant milestones
| Measure |
Picosure Laser System
Picosure Laser System for the treatment of unwanted tattoos
Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
|
|---|---|
|
Overall Study
STARTED
|
15
|
|
Overall Study
COMPLETED
|
8
|
|
Overall Study
NOT COMPLETED
|
7
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
One of the subjects did not report his/her race/ethnicity.
Baseline characteristics by cohort
| Measure |
Picosure Laser System
n=15 Participants
Picosure Laser System for the treatment of unwanted tattoos
Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=15 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
15 Participants
n=15 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=15 Participants
|
|
Sex: Female, Male
Female
|
9 Participants
n=15 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=15 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Caucasian
|
10 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
|
|
Race/Ethnicity, Customized
Race/Ethnicity · African American
|
3 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Asian
|
1 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Indian
|
0 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
|
0 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
|
|
Fitzpatrick Skin Type
Fitzpatrick Skin Type I
|
2 Participants
n=15 Participants
|
|
Fitzpatrick Skin Type
Fitzpatrick Skin Type II
|
5 Participants
n=15 Participants
|
|
Fitzpatrick Skin Type
Fitzpatrick Skin Type III
|
4 Participants
n=15 Participants
|
|
Fitzpatrick Skin Type
Fitzpatrick Skin Type IV
|
0 Participants
n=15 Participants
|
|
Fitzpatrick Skin Type
Fitzpatrick Skin Type V
|
3 Participants
n=15 Participants
|
|
Fitzpatrick Skin Type
Fitzpatrick Skin Type VI
|
1 Participants
n=15 Participants
|
PRIMARY outcome
Timeframe: 2 months post last treatmentTattoo clearance will be measured using baseline and 2 month post treatment photos using a photographic scale. The scale ranges from 0 to 10, where 10 is 100% improvement from the baseline photo.
Outcome measures
| Measure |
Picosure Laser System
n=8 Participants
Picosure Laser System for the treatment of unwanted tattoos
Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
|
|---|---|
|
Number of Patients With Tattoo Clearance
# of Patients with 20% Improvement
|
3 Participants
|
|
Number of Patients With Tattoo Clearance
# of Patients with 30% Improvement
|
5 Participants
|
SECONDARY outcome
Timeframe: 2 months post last treatmentThis measures the physician satisfaction from 1 to 5, where 5 is the most satisfied.
Outcome measures
| Measure |
Picosure Laser System
n=8 Participants
Picosure Laser System for the treatment of unwanted tattoos
Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
|
|---|---|
|
Physician Satisfaction Questionnaire
Patients scored a 5 by physician
|
4 Participants
|
|
Physician Satisfaction Questionnaire
Patients scored a 4 by Physician
|
4 Participants
|
Adverse Events
Picosure Laser System
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Picosure Laser System
n=15 participants at risk
Picosure Laser System for the treatment of unwanted tattoos
Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
|
|---|---|
|
Nervous system disorders
Pain
|
53.3%
8/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Blistering
|
46.7%
7/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Erythema
|
33.3%
5/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Edema
|
26.7%
4/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Bruising
|
6.7%
1/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Pinpoint Bleeding
|
26.7%
4/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Crusting
|
73.3%
11/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Itching
|
53.3%
8/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Allergic Reaction
|
13.3%
2/15 • Adverse events were collected for the study duration, around 19 months.
|
|
Skin and subcutaneous tissue disorders
Hypopigmentation
|
13.3%
2/15 • Adverse events were collected for the study duration, around 19 months.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The PI cannot disclose confidential or proprietary information until after it becomes generally known or available to the public.
- Publication restrictions are in place
Restriction type: OTHER